ClinVar Miner

Submissions for variant NM_001927.4(DES):c.1353C>G (p.Ile451Met) (rs121913002)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000056787 SCV000235800 uncertain significance not provided 2018-10-04 criteria provided, single submitter clinical testing The I451M variant in the DES gene has been reported in association with both DCM and skeletal myopathy (Li et al., 1999; Dalakas et al., 2000; Dalakas et al., 2003; Miyamoto et al., 2001). Li et al., (1999) identified I451M in a proband with familial DCM and not in 460 healthy control individuals, and reported that I451M co-segregated with disease in all affected family members; however, the variant exhibited incomplete penetrance. Miyamoto et al. (2000) identified I451M in 3/265 (1.1%) of Japanese patients with DCM and did not observe I451M in 359 healthy controls. Additionally, Dalakas et al. (2000; 2003) identified I451M in three individuals from a family affected with skeletal myopathy, without features of cardiomyopathy. The I451M variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The I451M variant is located in the tail domain of the human desmin protein (Li et al., 1999). Nevertheless, the I451M variant is a conservative amino acid substitution as these residues share similar properties, and is least likely to impact secondary structure. Although functional studies have shown that I451M mutants exhibit apparently normal intermediate filament network formation, I451M appears to interfere with binding to desmoplakin in vitro and disrupts localization to the Z-disc in transgenic mice (Lapouge et al., 2006; Mavroidis et al., 2008). Missense variants in nearby residues (K449M, K449T, T453I, R454W) have been reported in association with cardiomyopathy and desmin related myopathy, further supporting the functional importance of this region of the protein. In summary, I451M in the DES gene is interpreted as a variant of uncertain significance.
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000056787 SCV000343109 uncertain significance not provided 2016-08-12 criteria provided, single submitter clinical testing
Invitae RCV000698481 SCV000827147 uncertain significance Myofibrillar myopathy 1; Muscular dystrophy, limb-girdle, type 2R 2019-03-08 criteria provided, single submitter clinical testing This sequence change replaces isoleucine with methionine at codon 451 of the DES protein (p.Ile451Met). The isoleucine residue is moderately conserved and there is a small physicochemical difference between isoleucine and methionine. This variant is present in population databases (rs121913002, ExAC 0.02%). This variant has been reported in individuals affected with dilated cardiomyopathy (PMID: 11728149) and has been described to segregate with evidence of incomplete penetrance in a family with dilated cardiomyopathy (PMID: 10430757) and in a family with myofibrillar myopathy (PMID: 10717012). ClinVar contains an entry for this variant (Variation ID: 16824). Experimental studies have shown that this missense change is not expected to disrupt desmin protein assembly, but interferes with intermediate filament interactions in vitro (PMID: 17105773, 17221859) and inhibits desmin stabilization and its localization to the Z disc in transgenic mice (PMID: 18539904). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Illumina Clinical Services Laboratory,Illumina RCV001140631 SCV001300905 uncertain significance Myofibrillar myopathy 1 2018-07-10 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Illumina Clinical Services Laboratory,Illumina RCV000018318 SCV001300906 uncertain significance Dilated cardiomyopathy 1I 2017-11-28 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Illumina Clinical Services Laboratory,Illumina RCV001140632 SCV001300907 benign Neurogenic scapuloperoneal syndrome, Kaeser type 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.
OMIM RCV000018318 SCV000038597 pathogenic Dilated cardiomyopathy 1I 1999-08-03 no assertion criteria provided literature only
Epithelial Biology; Institute of Medical Biology, Singapore RCV000056787 SCV000087900 not provided not provided no assertion provided not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.